APO Research
Talk to an analyst

APO RESEARCH · REPORT

GPCR Screening Service

Compare research editions
View pricing & licenses

Selected research

Market Outlook & Growth Opportunities

Global GPCR Screening Service Market Outlook and Growth Opportunities 2026

4 July 2026212 pages

Choose your research edition.

Industry ResearchGPCR Screening Service Industry Research Report 2026141 pages · $2,950 USDIndustry Growth & TrendsGlobal GPCR Screening Service Industry Growth and Trends Forecast to 2032123 pages · $3,450 USDMarket StructureGlobal GPCR Screening Service Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032192 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal GPCR Screening Service Market Outlook and Growth Opportunities 2026212 pages · $4,250 USDMarket Analysis & ForecastGlobal GPCR Screening Service Market Analysis and Forecast 2026-2032193 pages · $4,950 USD

Market perspective

The global GPCR Screening Service market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.

The North America market for GPCR Screening Service is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for GPCR Screening Service is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for GPCR Screening Service is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

In China, the GPCR Screening Service market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Major global companies in the GPCR Screening Service market include Eurofins Discovery, Charles River Laboratories International, Inc., Reaction Biology Corporation, Sygnature Discovery Limited, Evotec SE, Multispan, Inc., Pharmaron Beijing Co., Ltd., PharmaLegacy Laboratories and BioAscent Discovery Limited, among others. In 2025, the top three vendors together accounted for approximately % of global market revenue.

This report provides an overview of the global GPCR Screening Service market in terms of revenue and gross margin, analyzing global market trends using historical revenue data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of GPCR Screening Service and market revenue by major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents GPCR Screening Service revenue, market share, and industry ranking for the main companies for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

Across the 2021-2026 period, the analysis compares revenue growth and profitability profiles by company, distinguishing participants with sustained expansion from those with more cyclical performance, and relates these patterns to differences in regional exposure, product portfolios, and application focus in the global GPCR Screening Service market.

GPCR Screening Service Segment by Company

Eurofins Discovery

Charles River Laboratories International, Inc.

Reaction Biology Corporation

Sygnature Discovery Limited

Evotec SE

Multispan, Inc.

Pharmaron Beijing Co., Ltd.

PharmaLegacy Laboratories

BioAscent Discovery Limited

Creative Biogene

Creative Bioarray

ICE Bioscience

Shanghai Jinsirui Vigorous Biotechnology Co., Ltd.

Promega Corporation

Proteros biostructures GmbH

Aragen Life Sciences

BPS Bioscience, Inc.

Revvity, Inc.

Genscript Biotech Corporation

Beijing Abace Biotechnology Co., Ltd.

MedChemExpress LLC

BrainVTA (Wuhan) Co., Ltd.

Genevoyager Biopharmaceutical Technology (Wuhan) Co., Ltd.

Penn State GPCR Assay Service Center

Celtarys Research

GPCR Screening Service Segment by Type

Gs Pathway Screening

Gi/o Pathway Screening

Gq Pathway Screening

G12/13 Pathway Screening

GPCR Screening Service Segment by Application

Pharmaceuticals

Disease Treatment

Research

Other

GPCR Screening Service Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Colombia

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global GPCR Screening Service status and future forecast, involving, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the GPCR Screening Service key companies, revenue, market share, and recent developments.

3. To split the GPCR Screening Service breakdown data by regions, type, companies, and application.

4. To analyze the global and key regions GPCR Screening Service market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify GPCR Screening Service significant trends, drivers, influence factors in global and regions.

6. To analyze GPCR Screening Service competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global GPCR Screening Service market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of GPCR Screening Service and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of GPCR Screening Service.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, global total market size.

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global GPCR Screening Service industry.

Chapter 3: Detailed analysis of GPCR Screening Service company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales value of GPCR Screening Service in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of key country in the world.

Chapter 7: Sales value of GPCR Screening Service in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.

Chapter 9: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. GPCR Screening Service Industry Trends Table 2. GPCR Screening Service Industry Drivers Table 3. GPCR Screening Service Industry Opportunities and Challenges Table 4. GPCR Screening Service Industry Restraints Table 5. Global GPCR Screening Service Revenue by Company (US$ Million) & (2021-2026) Table 6. Global GPCR Screening Service Revenue Share by Company (2021-2026) Table 7. Global GPCR Screening Service Company Ranking, (2024-2026) & (US$ Million) Table 8. Global GPCR Screening Service Key Company Manufacturing Base & Headquarters Table 9. Global GPCR Screening Service Company, Product Type & Application Table 10. Global GPCR Screening Service Company Establishment Date Table 11. Global Company Market Concentration Ratio (CR5 and HHI) Table 12. Global GPCR Screening Service by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 13. Mergers & Acquisitions, Expansion Table 14. Significant Companies of Gs Pathway Screening Table 15. Significant Companies of Gi/o Pathway Screening Table 16. Significant Companies of Gq Pathway Screening Table 17. Significant Companies of G12/13 Pathway Screening Table 18. Global GPCR Screening Service Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 19. Global GPCR Screening Service Sales Value by Type (2021-2026) & (US$ Million) Table 20. Global GPCR Screening Service Sales Value by Type (2027-2032) & (US$ Million) Table 21. Global GPCR Screening Service Sales Value Share by Type (2021-2026) Table 22. Global GPCR Screening Service Sales Value Share by Type (2027-2032) Table 23. Significant Companies of Pharmaceuticals Table 24. Significant Companies of Disease Treatment Table 25. Significant Companies of Research Table 26. Significant Companies of Other Table 27. Global GPCR Screening Service Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 28. Global GPCR Screening Service Sales Value by Application (2021-2026) & (US$ Million) Table 29. Global GPCR Screening Service Sales Value by Application (2027-2032) & (US$ Million) Table 30. Global GPCR Screening Service Sales Value Share by Application (2021-2026) Table 31. Global GPCR Screening Service Sales Value Share by Application (2027-2032) Table 32. Global GPCR Screening Service Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 33. Global GPCR Screening Service Sales Value by Region (2021-2026) & (US$ Million) Table 34. Global GPCR Screening Service Sales Value Share by Region (2021-2026) Table 35. Global GPCR Screening Service Sales Value by Region (2027-2032) & (US$ Million) Table 36. Global GPCR Screening Service Sales Value Share by Region (2027-2032) Table 37. Global GPCR Screening Service Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 38. Global GPCR Screening Service Sales Value by Country (2021-2026) & (US$ Million) Table 39. Global GPCR Screening Service Sales Value Market Share by Country (2021-2026) Table 40. Global GPCR Screening Service Sales Value by Country (2027-2032) & (US$ Million) Table 41. Global GPCR Screening Service Sales Value Market Share by Country (2027-2032) Table 42. Eurofins Discovery Company Information Table 43. Eurofins Discovery Business Overview Table 44. Eurofins Discovery GPCR Screening Service Revenue (US$ Million) and Gross Margin (2021-2026) Table 45. Eurofins Discovery GPCR Screening Service Product Portfolio Table 46. Eurofins Discovery Recent Development Table 47. Charles River Laboratories International, Inc. Company Information Table 48. Charles River Laboratories International, Inc. Business Overview Table 49. Charles River Laboratories International, Inc. GPCR Screening Service Revenue (US$ Million) and Gross Margin (2021-2026) Table 50. Charles River Laboratories International, Inc. GPCR Screening Service Product Portfolio Table 51. Charles River Laboratories International, Inc. Recent Development Table 52. Reaction Biology Corporation Company Information Table 53. Reaction Biology Corporation Business Overview Table 54. Reaction Biology Corporation GPCR Screening Service Revenue (US$ Million) and Gross Margin (2021-2026) Table 55. Reaction Biology Corporation GPCR Screening Service Product Portfolio Table 56. Reaction Biology Corporation Recent Development Table 57. Sygnature Discovery Limited Company Information Table 58. Sygnature Discovery Limited Business Overview Table 59. Sygnature Discovery Limited GPCR Screening Service Revenue (US$ Million) and Gross Margin (2021-2026) Table 60. Sygnature Discovery Limited GPCR Screening Service Product Portfolio Table 61. Sygnature Discovery Limited Recent Development Table 62. Evotec SE Company Information Table 63. Evotec SE Business Overview Table 64. Evotec SE GPCR Screening Service Revenue (US$ Million) and Gross Margin (2021-2026) Table 65. Evotec SE GPCR Screening Service Product Portfolio Table 66. Evotec SE Recent Development Table 67. Multispan, Inc. Company Information Table 68. Multispan, Inc. Business Overview Table 69. Multispan, Inc. GPCR Screening Service Revenue (US$ Million) and Gross Margin (2021-2026) Table 70. Multispan, Inc. GPCR Screening Service Product Portfolio Table 71. Multispan, Inc. Recent Development Table 72. Pharmaron Beijing Co., Ltd. Company Information Table 73. Pharmaron Beijing Co., Ltd. Business Overview Table 74. Pharmaron Beijing Co., Ltd. GPCR Screening Service Revenue (US$ Million) and Gross Margin (2021-2026) Table 75. Pharmaron Beijing Co., Ltd. GPCR Screening Service Product Portfolio Table 76. Pharmaron Beijing Co., Ltd. Recent Development Table 77. PharmaLegacy Laboratories Company Information Table 78. PharmaLegacy Laboratories Business Overview Table 79. PharmaLegacy Laboratories GPCR Screening Service Revenue (US$ Million) and Gross Margin (2021-2026) Table 80. PharmaLegacy Laboratories GPCR Screening Service Product Portfolio Table 81. PharmaLegacy Laboratories Recent Development Table 82. BioAscent Discovery Limited Company Information Table 83. BioAscent Discovery Limited Business Overview Table 84. BioAscent Discovery Limited GPCR Screening Service Revenue (US$ Million) and Gross Margin (2021-2026) Table 85. BioAscent Discovery Limited GPCR Screening Service Product Portfolio Table 86. BioAscent Discovery Limited Recent Development Table 87. Creative Biogene Company Information Table 88. Creative Biogene Business Overview Table 89. Creative Biogene GPCR Screening Service Revenue (US$ Million) and Gross Margin (2021-2026) Table 90. Creative Biogene GPCR Screening Service Product Portfolio Table 91. Creative Biogene Recent Development Table 92. Creative Bioarray Company Information Table 93. Creative Bioarray Business Overview Table 94. Creative Bioarray GPCR Screening Service Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 95. Creative Bioarray GPCR Screening Service Product Portfolio Table 96. Creative Bioarray Recent Development Table 97. ICE Bioscience Company Information Table 98. ICE Bioscience Business Overview Table 99. ICE Bioscience GPCR Screening Service Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 100. ICE Bioscience GPCR Screening Service Product Portfolio Table 101. ICE Bioscience Recent Development Table 102. Shanghai Jinsirui Vigorous Biotechnology Co., Ltd. Company Information Table 103. Shanghai Jinsirui Vigorous Biotechnology Co., Ltd. Business Overview Table 104. Shanghai Jinsirui Vigorous Biotechnology Co., Ltd. GPCR Screening Service Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 105. Shanghai Jinsirui Vigorous Biotechnology Co., Ltd. GPCR Screening Service Product Portfolio Table 106. Shanghai Jinsirui Vigorous Biotechnology Co., Ltd. Recent Development Table 107. Promega Corporation Company Information Table 108. Promega Corporation Business Overview Table 109. Promega Corporation GPCR Screening Service Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 110. Promega Corporation GPCR Screening Service Product Portfolio Table 111. Promega Corporation Recent Development Table 112. Proteros biostructures GmbH Company Information Table 113. Proteros biostructures GmbH Business Overview Table 114. Proteros biostructures GmbH GPCR Screening Service Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 115. Proteros biostructures GmbH GPCR Screening Service Product Portfolio Table 116. Proteros biostructures GmbH Recent Development Table 117. Aragen Life Sciences Company Information Table 118. Aragen Life Sciences Business Overview Table 119. Aragen Life Sciences GPCR Screening Service Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 120. Aragen Life Sciences GPCR Screening Service Product Portfolio Table 121. Aragen Life Sciences Recent Development Table 122. BPS Bioscience, Inc. Company Information Table 123. BPS Bioscience, Inc. Business Overview Table 124. BPS Bioscience, Inc. GPCR Screening Service Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 125. BPS Bioscience, Inc. GPCR Screening Service Product Portfolio Table 126. BPS Bioscience, Inc. Recent Development Table 127. Revvity, Inc. Company Information Table 128. Revvity, Inc. Business Overview Table 129. Revvity, Inc. GPCR Screening Service Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 130. Revvity, Inc. GPCR Screening Service Product Portfolio Table 131. Revvity, Inc. Recent Development Table 132. Genscript Biotech Corporation Company Information Table 133. Genscript Biotech Corporation Business Overview Table 134. Genscript Biotech Corporation GPCR Screening Service Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 135. Genscript Biotech Corporation GPCR Screening Service Product Portfolio Table 136. Genscript Biotech Corporation Recent Development Table 137. Beijing Abace Biotechnology Co., Ltd. Company Information Table 138. Beijing Abace Biotechnology Co., Ltd. Business Overview Table 139. Beijing Abace Biotechnology Co., Ltd. GPCR Screening Service Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 140. Beijing Abace Biotechnology Co., Ltd. GPCR Screening Service Product Portfolio Table 141. Beijing Abace Biotechnology Co., Ltd. Recent Development Table 142. MedChemExpress LLC Company Information Table 143. MedChemExpress LLC Business Overview Table 144. MedChemExpress LLC GPCR Screening Service Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 145. MedChemExpress LLC GPCR Screening Service Product Portfolio Table 146. MedChemExpress LLC Recent Development Table 147. BrainVTA (Wuhan) Co., Ltd. Company Information Table 148. BrainVTA (Wuhan) Co., Ltd. Business Overview Table 149. BrainVTA (Wuhan) Co., Ltd. GPCR Screening Service Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 150. BrainVTA (Wuhan) Co., Ltd. GPCR Screening Service Product Portfolio Table 151. BrainVTA (Wuhan) Co., Ltd. Recent Development Table 152. Genevoyager Biopharmaceutical Technology (Wuhan) Co., Ltd. Company Information Table 153. Genevoyager Biopharmaceutical Technology (Wuhan) Co., Ltd. Business Overview Table 154. Genevoyager Biopharmaceutical Technology (Wuhan) Co., Ltd. GPCR Screening Service Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 155. Genevoyager Biopharmaceutical Technology (Wuhan) Co., Ltd. GPCR Screening Service Product Portfolio Table 156. Genevoyager Biopharmaceutical Technology (Wuhan) Co., Ltd. Recent Development Table 157. Penn State GPCR Assay Service Center Company Information Table 158. Penn State GPCR Assay Service Center Business Overview Table 159. Penn State GPCR Assay Service Center GPCR Screening Service Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 160. Penn State GPCR Assay Service Center GPCR Screening Service Product Portfolio Table 161. Penn State GPCR Assay Service Center Recent Development Table 162. Celtarys Research Company Information Table 163. Celtarys Research Business Overview Table 164. Celtarys Research GPCR Screening Service Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 165. Celtarys Research GPCR Screening Service Product Portfolio Table 166. Celtarys Research Recent Development Table 167. Research Programs/Design for This Report Table 168. Authors List of This Report Table 169. Secondary Sources Table 170. Primary Sources List of Figures Figure 1. GPCR Screening Service Product Image Figure 2. Global GPCR Screening Service Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global GPCR Screening Service Market Size (2021-2032) & (US$ Million) Figure 4. Global GPCR Screening Service Company Revenue Ranking in 2025 (US$ Million) Figure 5. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 6. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 7. Gs Pathway Screening Image Figure 8. Gi/o Pathway Screening Image Figure 9. Gq Pathway Screening Image Figure 10. G12/13 Pathway Screening Image Figure 11. Global GPCR Screening Service Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 12. Global GPCR Screening Service Sales Value Share 2021 VS 2025 VS 2032 Figure 13. Global GPCR Screening Service Sales Value Share by Type (2021-2032) Figure 14. Pharmaceuticals Image Figure 15. Disease Treatment Image Figure 16. Research Image Figure 17. Other Image Figure 18. Global GPCR Screening Service Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 19. Global GPCR Screening Service Sales Value Share 2021 VS 2025 VS 2032 Figure 20. Global GPCR Screening Service Sales Value Share by Application (2021-2032) Figure 21. Global GPCR Screening Service Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 22. Global GPCR Screening Service Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 23. North America GPCR Screening Service Sales Value (2021-2032) & (US$ Million) Figure 24. North America GPCR Screening Service Sales Value Share by Country (%), 2025 VS 2032 Figure 25. Europe GPCR Screening Service Sales Value (2021-2032) & (US$ Million) Figure 26. Europe GPCR Screening Service Sales Value Share by Country (%), 2025 VS 2032 Figure 27. Asia-Pacific GPCR Screening Service Sales Value (2021-2032) & (US$ Million) Figure 28. Asia-Pacific GPCR Screening Service Sales Value Share by Country (%), 2025 VS 2032 Figure 29. South America GPCR Screening Service Sales Value (2021-2032) & (US$ Million) Figure 30. South America GPCR Screening Service Sales Value Share by Country (%), 2025 VS 2032 Figure 31. Middle East & Africa GPCR Screening Service Sales Value (2021-2032) & (US$ Million) Figure 32. Middle East & Africa GPCR Screening Service Sales Value Share by Country (%), 2025 VS 2032 Figure 33. USA GPCR Screening Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 34. USA GPCR Screening Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 35. USA GPCR Screening Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 36. Canada GPCR Screening Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 37. Canada GPCR Screening Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 38. Canada GPCR Screening Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 39. Mexico GPCR Screening Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 40. Mexico GPCR Screening Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 41. Mexico GPCR Screening Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 42. Germany GPCR Screening Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 43. Germany GPCR Screening Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 44. Germany GPCR Screening Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 45. France GPCR Screening Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 46. France GPCR Screening Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 47. France GPCR Screening Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 48. U.K. GPCR Screening Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 49. U.K. GPCR Screening Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 50. U.K. GPCR Screening Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 51. Italy GPCR Screening Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 52. Italy GPCR Screening Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 53. Italy GPCR Screening Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 54. Spain GPCR Screening Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 55. Spain GPCR Screening Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 56. Spain GPCR Screening Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 57. Russia GPCR Screening Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 58. Russia GPCR Screening Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 59. Russia GPCR Screening Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 60. Netherlands GPCR Screening Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 61. Netherlands GPCR Screening Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 62. Netherlands GPCR Screening Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 63. Nordic Countries GPCR Screening Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 64. Nordic Countries GPCR Screening Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 65. Nordic Countries GPCR Screening Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 66. China GPCR Screening Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 67. China GPCR Screening Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 68. China GPCR Screening Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 69. Japan GPCR Screening Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 70. Japan GPCR Screening Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 71. Japan GPCR Screening Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 72. South Korea GPCR Screening Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 73. South Korea GPCR Screening Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 74. South Korea GPCR Screening Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 75. India GPCR Screening Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 76. India GPCR Screening Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 77. India GPCR Screening Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 78. Australia GPCR Screening Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 79. Australia GPCR Screening Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 80. Australia GPCR Screening Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 81. Southeast Asia GPCR Screening Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 82. Southeast Asia GPCR Screening Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 83. Southeast Asia GPCR Screening Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 84. Brazil GPCR Screening Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 85. Brazil GPCR Screening Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 86. Brazil GPCR Screening Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 87. Argentina GPCR Screening Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 88. Argentina GPCR Screening Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 89. Argentina GPCR Screening Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 90. Chile GPCR Screening Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 91. Chile GPCR Screening Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 92. Chile GPCR Screening Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 93. Colombia GPCR Screening Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 94. Colombia GPCR Screening Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 95. Colombia GPCR Screening Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 96. Peru GPCR Screening Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 97. Peru GPCR Screening Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 98. Peru GPCR Screening Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 99. Saudi Arabia GPCR Screening Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 100. Saudi Arabia GPCR Screening Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 101. Saudi Arabia GPCR Screening Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 102. Israel GPCR Screening Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 103. Israel GPCR Screening Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 104. Israel GPCR Screening Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 105. UAE GPCR Screening Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 106. UAE GPCR Screening Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 107. UAE GPCR Screening Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 108. Turkey GPCR Screening Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 109. Turkey GPCR Screening Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 110. Turkey GPCR Screening Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 111. Iran GPCR Screening Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 112. Iran GPCR Screening Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 113. Iran GPCR Screening Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 114. Egypt GPCR Screening Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 115. Egypt GPCR Screening Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 116. Egypt GPCR Screening Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 117. Years Considered Figure 118. Research Process Figure 119. Key Executives Interviewed

Scope & coverage.

Types
  • Gs Pathway Screening
  • Gi/o Pathway Screening
  • Gq Pathway Screening
  • G12/13 Pathway Screening
Applications
  • Pharmaceuticals
  • Disease Treatment
  • Research
  • Other
Companies covered
  • Eurofins Discovery
  • Charles River Laboratories International, Inc.
  • Reaction Biology Corporation
  • Sygnature Discovery Limited
  • Evotec SE
  • Multispan, Inc.
  • Pharmaron Beijing Co., Ltd.
  • PharmaLegacy Laboratories
  • BioAscent Discovery Limited
  • Creative Biogene
  • Creative Bioarray
  • ICE Bioscience
  • Shanghai Jinsirui Vigorous Biotechnology Co., Ltd.
  • Promega Corporation
  • Proteros biostructures GmbH
  • Aragen Life Sciences
  • BPS Bioscience, Inc.
  • Revvity, Inc.
  • Genscript Biotech Corporation
  • Beijing Abace Biotechnology Co., Ltd.
  • MedChemExpress LLC
  • BrainVTA (Wuhan) Co., Ltd.
  • Genevoyager Biopharmaceutical Technology (Wuhan) Co., Ltd.
  • Penn State GPCR Assay Service Center
  • Celtarys Research

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global GPCR Screening Service Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global GPCR Screening Service Market Size (2021-2032)
  4. 1.4 Assumptions and Limitations
  5. 1.5 Study Goals and Objectives
2 GPCR Screening Service Market Dynamics
  1. 2.1 GPCR Screening Service Industry Trends
  2. 2.2 GPCR Screening Service Industry Drivers
  3. 2.3 GPCR Screening Service Industry Opportunities and Challenges
  4. 2.4 GPCR Screening Service Industry Restraints
3 GPCR Screening Service Market by Company
  1. 3.1 Global GPCR Screening Service Company Revenue Ranking in 2025
  2. 3.2 Global GPCR Screening Service Revenue by Company (2021-2026)
  3. 3.3 Global GPCR Screening Service Company Ranking (2024-2026)
  4. 3.4 Global GPCR Screening Service Company Manufacturing Base and Headquarters
  5. 3.5 Global GPCR Screening Service Company Product Type and Application
  6. 3.6 Global GPCR Screening Service Company Establishment Date
  7. 3.7 Market Competitive Analysis
  8. 3.7.1 Global GPCR Screening Service Market Concentration Ratio (CR5 and HHI)
  9. 3.7.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  10. 3.7.3 2025 GPCR Screening Service Tier 1, Tier 2, and Tier 3 Companies
  11. 3.8 Mergers and Acquisitions Expansion
4 GPCR Screening Service Market by Type
  1. 4.1 GPCR Screening Service Type Introduction
  2. 4.1.1 Gs Pathway Screening
  3. 4.1.2 Gi/o Pathway Screening
  4. 4.1.3 Gq Pathway Screening
  5. 4.1.4 G12/13 Pathway Screening
  6. 4.2 Global GPCR Screening Service Sales Value by Type
  7. 4.2.1 Global GPCR Screening Service Sales Value by Type (2021 VS 2025 VS 2032)
  8. 4.2.2 Global GPCR Screening Service Sales Value by Type (2021-2032)
  9. 4.2.3 Global GPCR Screening Service Sales Value Share by Type (2021-2032)
5 GPCR Screening Service Market by Application
  1. 5.1 GPCR Screening Service Application Introduction
  2. 5.1.1 Pharmaceuticals
  3. 5.1.2 Disease Treatment
  4. 5.1.3 Research
  5. 5.1.4 Other
  6. 5.2 Global GPCR Screening Service Sales Value by Application
  7. 5.2.1 Global GPCR Screening Service Sales Value by Application (2021 VS 2025 VS 2032)
  8. 5.2.2 Global GPCR Screening Service Sales Value by Application (2021-2032)
  9. 5.2.3 Global GPCR Screening Service Sales Value Share by Application (2021-2032)
6 GPCR Screening Service Regional Value Analysis
  1. 6.1 Global GPCR Screening Service Sales Value by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global GPCR Screening Service Sales Value by Region (2021-2032)
  3. 6.2.1 Global GPCR Screening Service Sales Value by Region: 2021-2026
  4. 6.2.2 Global GPCR Screening Service Sales Value by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America GPCR Screening Service Sales Value (2021-2032)
  7. 6.3.2 North America GPCR Screening Service Sales Value Share by Country, 2025 VS 2032
  8. 6.4 Europe
  9. 6.4.1 Europe GPCR Screening Service Sales Value (2021-2032)
  10. 6.4.2 Europe GPCR Screening Service Sales Value Share by Country, 2025 VS 2032
  11. 6.5 Asia-Pacific
  12. 6.5.1 Asia-Pacific GPCR Screening Service Sales Value (2021-2032)
  13. 6.5.2 Asia-Pacific GPCR Screening Service Sales Value Share by Country, 2025 VS 2032
  14. 6.6 South America
  15. 6.6.1 South America GPCR Screening Service Sales Value (2021-2032)
  16. 6.6.2 South America GPCR Screening Service Sales Value Share by Country, 2025 VS 2032
  17. 6.7 Middle East & Africa
  18. 6.7.1 Middle East & Africa GPCR Screening Service Sales Value (2021-2032)
  19. 6.7.2 Middle East & Africa GPCR Screening Service Sales Value Share by Country, 2025 VS 2032
7 GPCR Screening Service Country-level Value Analysis
  1. 7.1 Global GPCR Screening Service Sales Value by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global GPCR Screening Service Sales Value by Country (2021-2032)
  3. 7.2.1 Global GPCR Screening Service Sales Value by Country (2021-2026)
  4. 7.2.2 Global GPCR Screening Service Sales Value by Country (2027-2032)
  5. 7.3 USA
  6. 7.3.1 USA GPCR Screening Service Sales Value Growth Rate (2021-2032)
  7. 7.3.2 USA GPCR Screening Service Sales Value Share by Type, 2025 VS 2032
  8. 7.3.3 USA GPCR Screening Service Sales Value Share by Application, 2025 VS 2032
  9. 7.4 Canada
  10. 7.4.1 Canada GPCR Screening Service Sales Value Growth Rate (2021-2032)
  11. 7.4.2 Canada GPCR Screening Service Sales Value Share by Type, 2025 VS 2032
  12. 7.4.3 Canada GPCR Screening Service Sales Value Share by Application, 2025 VS 2032
  13. 7.5 Mexico
  14. 7.5.1 Mexico GPCR Screening Service Sales Value Growth Rate (2021-2032)
  15. 7.5.2 Mexico GPCR Screening Service Sales Value Share by Type, 2025 VS 2032
  16. 7.5.3 Mexico GPCR Screening Service Sales Value Share by Application, 2025 VS 2032
  17. 7.6 Germany
  18. 7.6.1 Germany GPCR Screening Service Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Germany GPCR Screening Service Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Germany GPCR Screening Service Sales Value Share by Application, 2025 VS 2032
  21. 7.7 France
  22. 7.7.1 France GPCR Screening Service Sales Value Growth Rate (2021-2032)
  23. 7.7.2 France GPCR Screening Service Sales Value Share by Type, 2025 VS 2032
  24. 7.7.3 France GPCR Screening Service Sales Value Share by Application, 2025 VS 2032
  25. 7.8 U.K.
  26. 7.8.1 U.K. GPCR Screening Service Sales Value Growth Rate (2021-2032)
  27. 7.8.2 U.K. GPCR Screening Service Sales Value Share by Type, 2025 VS 2032
  28. 7.8.3 U.K. GPCR Screening Service Sales Value Share by Application, 2025 VS 2032
  29. 7.9 Italy
  30. 7.9.1 Italy GPCR Screening Service Sales Value Growth Rate (2021-2032)
  31. 7.9.2 Italy GPCR Screening Service Sales Value Share by Type, 2025 VS 2032
  32. 7.9.3 Italy GPCR Screening Service Sales Value Share by Application, 2025 VS 2032
  33. 7.10 Spain
  34. 7.10.1 Spain GPCR Screening Service Sales Value Growth Rate (2021-2032)
  35. 7.10.2 Spain GPCR Screening Service Sales Value Share by Type, 2025 VS 2032
  36. 7.10.3 Spain GPCR Screening Service Sales Value Share by Application, 2025 VS 2032
  37. 7.11 Russia
  38. 7.11.1 Russia GPCR Screening Service Sales Value Growth Rate (2021-2032)
  39. 7.11.2 Russia GPCR Screening Service Sales Value Share by Type, 2025 VS 2032
  40. 7.11.3 Russia GPCR Screening Service Sales Value Share by Application, 2025 VS 2032
  41. 7.12 Netherlands
  42. 7.12.1 Netherlands GPCR Screening Service Sales Value Growth Rate (2021-2032)
  43. 7.12.2 Netherlands GPCR Screening Service Sales Value Share by Type, 2025 VS 2032
  44. 7.12.3 Netherlands GPCR Screening Service Sales Value Share by Application, 2025 VS 2032
  45. 7.13 Nordic Countries
  46. 7.13.1 Nordic Countries GPCR Screening Service Sales Value Growth Rate (2021-2032)
  47. 7.13.2 Nordic Countries GPCR Screening Service Sales Value Share by Type, 2025 VS 2032
  48. 7.13.3 Nordic Countries GPCR Screening Service Sales Value Share by Application, 2025 VS 2032
  49. 7.14 China
  50. 7.14.1 China GPCR Screening Service Sales Value Growth Rate (2021-2032)
  51. 7.14.2 China GPCR Screening Service Sales Value Share by Type, 2025 VS 2032
  52. 7.14.3 China GPCR Screening Service Sales Value Share by Application, 2025 VS 2032
  53. 7.15 Japan
  54. 7.15.1 Japan GPCR Screening Service Sales Value Growth Rate (2021-2032)
  55. 7.15.2 Japan GPCR Screening Service Sales Value Share by Type, 2025 VS 2032
  56. 7.15.3 Japan GPCR Screening Service Sales Value Share by Application, 2025 VS 2032
  57. 7.16 South Korea
  58. 7.16.1 South Korea GPCR Screening Service Sales Value Growth Rate (2021-2032)
  59. 7.16.2 South Korea GPCR Screening Service Sales Value Share by Type, 2025 VS 2032
  60. 7.16.3 South Korea GPCR Screening Service Sales Value Share by Application, 2025 VS 2032
  61. 7.17 India
  62. 7.17.1 India GPCR Screening Service Sales Value Growth Rate (2021-2032)
  63. 7.17.2 India GPCR Screening Service Sales Value Share by Type, 2025 VS 2032
  64. 7.17.3 India GPCR Screening Service Sales Value Share by Application, 2025 VS 2032
  65. 7.18 Australia
  66. 7.18.1 Australia GPCR Screening Service Sales Value Growth Rate (2021-2032)
  67. 7.18.2 Australia GPCR Screening Service Sales Value Share by Type, 2025 VS 2032
  68. 7.18.3 Australia GPCR Screening Service Sales Value Share by Application, 2025 VS 2032
  69. 7.19 Southeast Asia
  70. 7.19.1 Southeast Asia GPCR Screening Service Sales Value Growth Rate (2021-2032)
  71. 7.19.2 Southeast Asia GPCR Screening Service Sales Value Share by Type, 2025 VS 2032
  72. 7.19.3 Southeast Asia GPCR Screening Service Sales Value Share by Application, 2025 VS 2032
  73. 7.20 Brazil
  74. 7.20.1 Brazil GPCR Screening Service Sales Value Growth Rate (2021-2032)
  75. 7.20.2 Brazil GPCR Screening Service Sales Value Share by Type, 2025 VS 2032
  76. 7.20.3 Brazil GPCR Screening Service Sales Value Share by Application, 2025 VS 2032
  77. 7.21 Argentina
  78. 7.21.1 Argentina GPCR Screening Service Sales Value Growth Rate (2021-2032)
  79. 7.21.2 Argentina GPCR Screening Service Sales Value Share by Type, 2025 VS 2032
  80. 7.21.3 Argentina GPCR Screening Service Sales Value Share by Application, 2025 VS 2032
  81. 7.22 Chile
  82. 7.22.1 Chile GPCR Screening Service Sales Value Growth Rate (2021-2032)
  83. 7.22.2 Chile GPCR Screening Service Sales Value Share by Type, 2025 VS 2032
  84. 7.22.3 Chile GPCR Screening Service Sales Value Share by Application, 2025 VS 2032
  85. 7.23 Colombia
  86. 7.23.1 Colombia GPCR Screening Service Sales Value Growth Rate (2021-2032)
  87. 7.23.2 Colombia GPCR Screening Service Sales Value Share by Type, 2025 VS 2032
  88. 7.23.3 Colombia GPCR Screening Service Sales Value Share by Application, 2025 VS 2032
  89. 7.24 Peru
  90. 7.24.1 Peru GPCR Screening Service Sales Value Growth Rate (2021-2032)
  91. 7.24.2 Peru GPCR Screening Service Sales Value Share by Type, 2025 VS 2032
  92. 7.24.3 Peru GPCR Screening Service Sales Value Share by Application, 2025 VS 2032
  93. 7.25 Saudi Arabia
  94. 7.25.1 Saudi Arabia GPCR Screening Service Sales Value Growth Rate (2021-2032)
  95. 7.25.2 Saudi Arabia GPCR Screening Service Sales Value Share by Type, 2025 VS 2032
  96. 7.25.3 Saudi Arabia GPCR Screening Service Sales Value Share by Application, 2025 VS 2032
  97. 7.26 Israel
  98. 7.26.1 Israel GPCR Screening Service Sales Value Growth Rate (2021-2032)
  99. 7.26.2 Israel GPCR Screening Service Sales Value Share by Type, 2025 VS 2032
  100. 7.26.3 Israel GPCR Screening Service Sales Value Share by Application, 2025 VS 2032
  101. 7.27 UAE
  102. 7.27.1 UAE GPCR Screening Service Sales Value Growth Rate (2021-2032)
  103. 7.27.2 UAE GPCR Screening Service Sales Value Share by Type, 2025 VS 2032
  104. 7.27.3 UAE GPCR Screening Service Sales Value Share by Application, 2025 VS 2032
  105. 7.28 Turkey
  106. 7.28.1 Turkey GPCR Screening Service Sales Value Growth Rate (2021-2032)
  107. 7.28.2 Turkey GPCR Screening Service Sales Value Share by Type, 2025 VS 2032
  108. 7.28.3 Turkey GPCR Screening Service Sales Value Share by Application, 2025 VS 2032
  109. 7.29 Iran
  110. 7.29.1 Iran GPCR Screening Service Sales Value Growth Rate (2021-2032)
  111. 7.29.2 Iran GPCR Screening Service Sales Value Share by Type, 2025 VS 2032
  112. 7.29.3 Iran GPCR Screening Service Sales Value Share by Application, 2025 VS 2032
  113. 7.30 Egypt
  114. 7.30.1 Egypt GPCR Screening Service Sales Value Growth Rate (2021-2032)
  115. 7.30.2 Egypt GPCR Screening Service Sales Value Share by Type, 2025 VS 2032
  116. 7.30.3 Egypt GPCR Screening Service Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 Eurofins Discovery
  2. 8.1.1 Eurofins Discovery Company Information
  3. 8.1.2 Eurofins Discovery Business Overview
  4. 8.1.3 Eurofins Discovery GPCR Screening Service Revenue and Gross Margin (2021-2026)
  5. 8.1.4 Eurofins Discovery GPCR Screening Service Product Portfolio
  6. 8.1.5 Eurofins Discovery Recent Developments
  7. 8.2 Charles River Laboratories International, Inc.
  8. 8.2.1 Charles River Laboratories International, Inc. Company Information
  9. 8.2.2 Charles River Laboratories International, Inc. Business Overview
  10. 8.2.3 Charles River Laboratories International, Inc. GPCR Screening Service Revenue and Gross Margin (2021-2026)
  11. 8.2.4 Charles River Laboratories International, Inc. GPCR Screening Service Product Portfolio
  12. 8.2.5 Charles River Laboratories International, Inc. Recent Developments
  13. 8.3 Reaction Biology Corporation
  14. 8.3.1 Reaction Biology Corporation Company Information
  15. 8.3.2 Reaction Biology Corporation Business Overview
  16. 8.3.3 Reaction Biology Corporation GPCR Screening Service Revenue and Gross Margin (2021-2026)
  17. 8.3.4 Reaction Biology Corporation GPCR Screening Service Product Portfolio
  18. 8.3.5 Reaction Biology Corporation Recent Developments
  19. 8.4 Sygnature Discovery Limited
  20. 8.4.1 Sygnature Discovery Limited Company Information
  21. 8.4.2 Sygnature Discovery Limited Business Overview
  22. 8.4.3 Sygnature Discovery Limited GPCR Screening Service Revenue and Gross Margin (2021-2026)
  23. 8.4.4 Sygnature Discovery Limited GPCR Screening Service Product Portfolio
  24. 8.4.5 Sygnature Discovery Limited Recent Developments
  25. 8.5 Evotec SE
  26. 8.5.1 Evotec SE Company Information
  27. 8.5.2 Evotec SE Business Overview
  28. 8.5.3 Evotec SE GPCR Screening Service Revenue and Gross Margin (2021-2026)
  29. 8.5.4 Evotec SE GPCR Screening Service Product Portfolio
  30. 8.5.5 Evotec SE Recent Developments
  31. 8.6 Multispan, Inc.
  32. 8.6.1 Multispan, Inc. Company Information
  33. 8.6.2 Multispan, Inc. Business Overview
  34. 8.6.3 Multispan, Inc. GPCR Screening Service Revenue and Gross Margin (2021-2026)
  35. 8.6.4 Multispan, Inc. GPCR Screening Service Product Portfolio
  36. 8.6.5 Multispan, Inc. Recent Developments
  37. 8.7 Pharmaron Beijing Co., Ltd.
  38. 8.7.1 Pharmaron Beijing Co., Ltd. Company Information
  39. 8.7.2 Pharmaron Beijing Co., Ltd. Business Overview
  40. 8.7.3 Pharmaron Beijing Co., Ltd. GPCR Screening Service Revenue and Gross Margin (2021-2026)
  41. 8.7.4 Pharmaron Beijing Co., Ltd. GPCR Screening Service Product Portfolio
  42. 8.7.5 Pharmaron Beijing Co., Ltd. Recent Developments
  43. 8.8 PharmaLegacy Laboratories
  44. 8.8.1 PharmaLegacy Laboratories Company Information
  45. 8.8.2 PharmaLegacy Laboratories Business Overview
  46. 8.8.3 PharmaLegacy Laboratories GPCR Screening Service Revenue and Gross Margin (2021-2026)
  47. 8.8.4 PharmaLegacy Laboratories GPCR Screening Service Product Portfolio
  48. 8.8.5 PharmaLegacy Laboratories Recent Developments
  49. 8.9 BioAscent Discovery Limited
  50. 8.9.1 BioAscent Discovery Limited Company Information
  51. 8.9.2 BioAscent Discovery Limited Business Overview
  52. 8.9.3 BioAscent Discovery Limited GPCR Screening Service Revenue and Gross Margin (2021-2026)
  53. 8.9.4 BioAscent Discovery Limited GPCR Screening Service Product Portfolio
  54. 8.9.5 BioAscent Discovery Limited Recent Developments
  55. 8.10 Creative Biogene
  56. 8.10.1 Creative Biogene Company Information
  57. 8.10.2 Creative Biogene Business Overview
  58. 8.10.3 Creative Biogene GPCR Screening Service Revenue and Gross Margin (2021-2026)
  59. 8.10.4 Creative Biogene GPCR Screening Service Product Portfolio
  60. 8.10.5 Creative Biogene Recent Developments
  61. 8.11 Creative Bioarray
  62. 8.11.1 Creative Bioarray Company Information
  63. 8.11.2 Creative Bioarray Business Overview
  64. 8.11.3 Creative Bioarray GPCR Screening Service Revenue and Gross Margin (2021-2026)
  65. 8.11.4 Creative Bioarray GPCR Screening Service Product Portfolio
  66. 8.11.5 Creative Bioarray Recent Developments
  67. 8.12 ICE Bioscience
  68. 8.12.1 ICE Bioscience Company Information
  69. 8.12.2 ICE Bioscience Business Overview
  70. 8.12.3 ICE Bioscience GPCR Screening Service Revenue and Gross Margin (2021-2026)
  71. 8.12.4 ICE Bioscience GPCR Screening Service Product Portfolio
  72. 8.12.5 ICE Bioscience Recent Developments
  73. 8.13 Shanghai Jinsirui Vigorous Biotechnology Co., Ltd.
  74. 8.13.1 Shanghai Jinsirui Vigorous Biotechnology Co., Ltd. Company Information
  75. 8.13.2 Shanghai Jinsirui Vigorous Biotechnology Co., Ltd. Business Overview
  76. 8.13.3 Shanghai Jinsirui Vigorous Biotechnology Co., Ltd. GPCR Screening Service Revenue and Gross Margin (2021-2026)
  77. 8.13.4 Shanghai Jinsirui Vigorous Biotechnology Co., Ltd. GPCR Screening Service Product Portfolio
  78. 8.13.5 Shanghai Jinsirui Vigorous Biotechnology Co., Ltd. Recent Developments
  79. 8.14 Promega Corporation
  80. 8.14.1 Promega Corporation Company Information
  81. 8.14.2 Promega Corporation Business Overview
  82. 8.14.3 Promega Corporation GPCR Screening Service Revenue and Gross Margin (2021-2026)
  83. 8.14.4 Promega Corporation GPCR Screening Service Product Portfolio
  84. 8.14.5 Promega Corporation Recent Developments
  85. 8.15 Proteros biostructures GmbH
  86. 8.15.1 Proteros biostructures GmbH Company Information
  87. 8.15.2 Proteros biostructures GmbH Business Overview
  88. 8.15.3 Proteros biostructures GmbH GPCR Screening Service Revenue and Gross Margin (2021-2026)
  89. 8.15.4 Proteros biostructures GmbH GPCR Screening Service Product Portfolio
  90. 8.15.5 Proteros biostructures GmbH Recent Developments
  91. 8.16 Aragen Life Sciences
  92. 8.16.1 Aragen Life Sciences Company Information
  93. 8.16.2 Aragen Life Sciences Business Overview
  94. 8.16.3 Aragen Life Sciences GPCR Screening Service Revenue and Gross Margin (2021-2026)
  95. 8.16.4 Aragen Life Sciences GPCR Screening Service Product Portfolio
  96. 8.16.5 Aragen Life Sciences Recent Developments
  97. 8.17 BPS Bioscience, Inc.
  98. 8.17.1 BPS Bioscience, Inc. Company Information
  99. 8.17.2 BPS Bioscience, Inc. Business Overview
  100. 8.17.3 BPS Bioscience, Inc. GPCR Screening Service Revenue and Gross Margin (2021-2026)
  101. 8.17.4 BPS Bioscience, Inc. GPCR Screening Service Product Portfolio
  102. 8.17.5 BPS Bioscience, Inc. Recent Developments
  103. 8.18 Revvity, Inc.
  104. 8.18.1 Revvity, Inc. Company Information
  105. 8.18.2 Revvity, Inc. Business Overview
  106. 8.18.3 Revvity, Inc. GPCR Screening Service Revenue and Gross Margin (2021-2026)
  107. 8.18.4 Revvity, Inc. GPCR Screening Service Product Portfolio
  108. 8.18.5 Revvity, Inc. Recent Developments
  109. 8.19 Genscript Biotech Corporation
  110. 8.19.1 Genscript Biotech Corporation Company Information
  111. 8.19.2 Genscript Biotech Corporation Business Overview
  112. 8.19.3 Genscript Biotech Corporation GPCR Screening Service Revenue and Gross Margin (2021-2026)
  113. 8.19.4 Genscript Biotech Corporation GPCR Screening Service Product Portfolio
  114. 8.19.5 Genscript Biotech Corporation Recent Developments
  115. 8.20 Beijing Abace Biotechnology Co., Ltd.
  116. 8.20.1 Beijing Abace Biotechnology Co., Ltd. Company Information
  117. 8.20.2 Beijing Abace Biotechnology Co., Ltd. Business Overview
  118. 8.20.3 Beijing Abace Biotechnology Co., Ltd. GPCR Screening Service Revenue and Gross Margin (2021-2026)
  119. 8.20.4 Beijing Abace Biotechnology Co., Ltd. GPCR Screening Service Product Portfolio
  120. 8.20.5 Beijing Abace Biotechnology Co., Ltd. Recent Developments
  121. 8.21 MedChemExpress LLC
  122. 8.21.1 MedChemExpress LLC Company Information
  123. 8.21.2 MedChemExpress LLC Business Overview
  124. 8.21.3 MedChemExpress LLC GPCR Screening Service Revenue and Gross Margin (2021-2026)
  125. 8.21.4 MedChemExpress LLC GPCR Screening Service Product Portfolio
  126. 8.21.5 MedChemExpress LLC Recent Developments
  127. 8.22 BrainVTA (Wuhan) Co., Ltd.
  128. 8.22.1 BrainVTA (Wuhan) Co., Ltd. Company Information
  129. 8.22.2 BrainVTA (Wuhan) Co., Ltd. Business Overview
  130. 8.22.3 BrainVTA (Wuhan) Co., Ltd. GPCR Screening Service Revenue and Gross Margin (2021-2026)
  131. 8.22.4 BrainVTA (Wuhan) Co., Ltd. GPCR Screening Service Product Portfolio
  132. 8.22.5 BrainVTA (Wuhan) Co., Ltd. Recent Developments
  133. 8.23 Genevoyager Biopharmaceutical Technology (Wuhan) Co., Ltd.
  134. 8.23.1 Genevoyager Biopharmaceutical Technology (Wuhan) Co., Ltd. Company Information
  135. 8.23.2 Genevoyager Biopharmaceutical Technology (Wuhan) Co., Ltd. Business Overview
  136. 8.23.3 Genevoyager Biopharmaceutical Technology (Wuhan) Co., Ltd. GPCR Screening Service Revenue and Gross Margin (2021-2026)
  137. 8.23.4 Genevoyager Biopharmaceutical Technology (Wuhan) Co., Ltd. GPCR Screening Service Product Portfolio
  138. 8.23.5 Genevoyager Biopharmaceutical Technology (Wuhan) Co., Ltd. Recent Developments
  139. 8.24 Penn State GPCR Assay Service Center
  140. 8.24.1 Penn State GPCR Assay Service Center Company Information
  141. 8.24.2 Penn State GPCR Assay Service Center Business Overview
  142. 8.24.3 Penn State GPCR Assay Service Center GPCR Screening Service Revenue and Gross Margin (2021-2026)
  143. 8.24.4 Penn State GPCR Assay Service Center GPCR Screening Service Product Portfolio
  144. 8.24.5 Penn State GPCR Assay Service Center Recent Developments
  145. 8.25 Celtarys Research
  146. 8.25.1 Celtarys Research Company Information
  147. 8.25.2 Celtarys Research Business Overview
  148. 8.25.3 Celtarys Research GPCR Screening Service Revenue and Gross Margin (2021-2026)
  149. 8.25.4 Celtarys Research GPCR Screening Service Product Portfolio
  150. 8.25.5 Celtarys Research Recent Developments
9 Concluding Insights
    10 Appendix
    1. 10.1 Reasons for Doing This Study
    2. 10.2 Research Methodology
    3. 10.3 Research Process
    4. 10.4 Authors List of This Report
    5. 10.5 Data Source
    6. 10.5.1 Secondary Sources
    7. 10.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst